![Ben Nichols](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Nichols
Amministratore Delegato presso Haemostatix Ltd.
Profilo
Ben Nichols is currently the Chief Executive Officer & Director at Haemostatix Ltd.
and the Chief Executive Officer at Alveron Pharma BV.
Previously, he worked as the Chief Executive Officer at Kings Holdings LLC, Director-Business Development at Plasso Technology Ltd., Principal at Lonza Biologics Plc, and General Manager at Cenes Ltd.
Posizioni attive di Ben Nichols
Società | Posizione | Inizio |
---|---|---|
Haemostatix Ltd.
![]() Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Amministratore Delegato | - |
Alveron Pharma BV
![]() Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Amministratore Delegato | 01/03/2019 |
Precedenti posizioni note di Ben Nichols
Società | Posizione | Fine |
---|---|---|
Lonza Biologics Plc
![]() Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Corporate Officer/Principal | - |
Kings Holdings LLC
![]() Kings Holdings LLC Other Consumer ServicesConsumer Services Kings' Holdings LLC Owns and operates educational institutions. The company holds and manages Schools and learning facilities. The company was founded in 2004 and it is headquartered in Dubai, United Arab Emirates. | Presidente | - |
Cenes Ltd.
![]() Cenes Ltd. Medical SpecialtiesHealth Technology Part of PAION AG, Cenes Ltd. develops treatments for diseases of the central nervous system. The company is based in Histon, UK. | Corporate Officer/Principal | - |
Plasso Technology Ltd.
![]() Plasso Technology Ltd. Medical/Nursing ServicesHealth Services Part of BD Biosciences, Systems & Reagents, Inc., Plasso Technology Ltd. provides medical technology services. The company is based in Sheffield, UK. Plasso Technology was acquired by BD Biosciences, Systems & Reagents, Inc. on May 04, 2007 for $10.42 million. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Lonza Biologics Plc
![]() Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Commercial Services |
Cenes Ltd.
![]() Cenes Ltd. Medical SpecialtiesHealth Technology Part of PAION AG, Cenes Ltd. develops treatments for diseases of the central nervous system. The company is based in Histon, UK. | Health Technology |
Plasso Technology Ltd.
![]() Plasso Technology Ltd. Medical/Nursing ServicesHealth Services Part of BD Biosciences, Systems & Reagents, Inc., Plasso Technology Ltd. provides medical technology services. The company is based in Sheffield, UK. Plasso Technology was acquired by BD Biosciences, Systems & Reagents, Inc. on May 04, 2007 for $10.42 million. | Health Services |
Haemostatix Ltd.
![]() Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Kings Holdings LLC
![]() Kings Holdings LLC Other Consumer ServicesConsumer Services Kings' Holdings LLC Owns and operates educational institutions. The company holds and manages Schools and learning facilities. The company was founded in 2004 and it is headquartered in Dubai, United Arab Emirates. | Consumer Services |
Alveron Pharma BV
![]() Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Ben Nichols